Arrowstreet Capital’s Amryt Pharma AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-64,483
Closed -$940K – 1553
2023
Q1
$940K Buy
+64,483
New +$911K ﹤0.01% 1078

Arrowstreet Capital's AMYT Position: Q2 2023 in Review

Arrowstreet Capital sold out of Amryt Pharma (AMYT) in Q2 2023, closing a stake of 64,483 shares — an estimated $940K sold.

Arrowstreet Capital first reported a position in AMYT in Q1 2023 and held it in 1 quarter. The position peaked at $940K in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

  • Arrowstreet Capital reported no remaining Amryt Pharma position as of Q2 2023 after selling out during the quarter.
  • Arrowstreet Capital sold 64,483 Amryt Pharma shares in Q2 2023, an estimated $940K.
  • Arrowstreet Capital first reported a position in Amryt Pharma in Q1 2023 and held it in 1 quarter.
  • Arrowstreet Capital's Amryt Pharma position peaked at $940K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Amryt Pharma as of Q2 2023.

Based on Arrowstreet Capital's 13F filing for Q2 2023, filed 14 Aug 2023.